To this aim, BKV/Tat mice bearing initial KS-like lesions or no lesion were injected locally with a mixture of IL-1, TNF-α, and IFN-γ three times (day 0, 4, 8) and were monitored up to 10 weeks as compared with untreated mice. This evidence concerns the gene IL1B and Kaposi's sarcoma.